NCT06214403View on ClinicalTrials.gov

Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

July 31, 2027

Conditions
Gram-negative BacteremiaMicrobial ColonizationAntibiotic Resistant Infection
Interventions
DRUG

MET-2

Microbial Ecosystem Therapeutics (MET) is a defined microbial community derived from healthy donor stool. MET capsules are orally administered mixtures of pure cultures of human-derived bacterial strains.

DRUG

Placebo

Microcrystalline Cellulose

Trial Locations (4)

K1Y 4E9

The Ottawa Hospital, Ottawa

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5G 1L7

University Health Network, Toronto

M6G 1X5

Sinai Health, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER